Skip to main content
. 2020 Oct 17;12(10):3021. doi: 10.3390/cancers12103021

Figure 5.

Figure 5

Flow chart. Black fields and arrows represent HER2 positive patient selection; grey fields and arrows represent HER2 negative or unknown patient selection; HER2: human epidermal growth factor receptor 2; HR: hormone receptor; pos: positive; TNBC: triple negative breast cancer; PTZ: pertuzumab; T-DM1: trastuzumab emtansine; FU time: follow-up time.